Biostatistics, Epidemiology, and Research Design Core

生物统计学、流行病学和研究设计核心

基本信息

  • 批准号:
    10281545
  • 负责人:
  • 金额:
    $ 54.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

Substantial gaps in methodological and statistical support undermine the conduct of scientifically rigorous and culturally responsive clinical and translational research (CTR), especially at the translational Stage T3 to T5. To fill these gaps, the Biostatistics, Epidemiology, and Research Design (BERD) Core will feature seven distinct components: Biostatistics, Epidemiology, Research Design, Data Science, Psychometrics, Mixed Methods, and Economic Analysis. BERD Core’s objective will be to provide resources and strengthen the skills of junior investigators (JI) and established investigators transitioning to CTR in conducting well-designed CTR that reduce the health disparities affecting Indigenous Pacific Peoples (IPP), defined as Native Hawaiians, Other Pacific Islanders, Filipinos, and other medically underserved and vulnerable populations in Hawaii. Specific Aim 1: Provide customized services for the design and analysis of health-disparities CTR by optimizing the use of BERD Core services through leveraging of existing resources and implementing an effective operational plan that recruits appropriate personnel, publicizes resources, and assists users; by assisting investigators in capturing appropriate valid data; by supporting investigators in developing comprehensive, high-quality, unbiased, efficient, reliable, and culturally responsive study designs, including those that address bias in methodology; and by prioritizing support for IPP health-disparities CTR, particularly trials of efficacy (T3) and effectiveness (T4) and adoption and institutionalization (T5). Specific Aim 2: Provide education and training on health-disparities CTR methodologies by mentoring JI/EI in the use of BERD tools and methods appropriate to CTR; by fostering and facilitating environments conducive to career enhancement, emphasizing the preparation and submission of meritorious research proposals by JI/EI, especially those of IPP descent; by designing and promoting an academic- engagement program on research methods and processes; and by creating and promoting a novel outreach program to provide support, mentoring, and education on study design, data analysis, and communication to community partners. Specific Aim 3: Develop tools and methods that maximize the quality of health-disparities CTR by establishing/integrating research designs and biostatistics essential to CTR; by creating design and analysis plans for studies of unique, underserved, or vulnerable populations; by advancing design and analysis plans for studies of small numbers of participants; and developing innovative methods to enhance statistical power. By the end of 5 years, the BERD Core will advance the CTR careers of junior investigators and other transitioning investigators, especially those with IPP backgrounds by supporting their efforts to secure federal funding to conduct independent research aimed at improving the health of IPP and other underserved and vulnerable populations in Hawaii.
在方法和统计支持方面的巨大差距妨碍了科学严谨的 和文化响应的临床和转化研究(CTR),特别是在转化阶段T3, T5为了填补这些空白,生物统计学,流行病学和研究设计(BERD)核心将包括七个 不同的组成部分:生物统计学,流行病学,研究设计,数据科学,心理测量学,混合 方法和经济分析。BERD核心的目标是提供资源和加强技能, 初级研究者(JI)和资深研究者在进行精心设计的CTR时过渡到CTR 减少影响被定义为夏威夷土著人的太平洋土著人民(IPP)的健康差距, 其他太平洋岛民、菲律宾人和夏威夷其他医疗服务不足和弱势群体。 具体目标1:为设计和分析健康差距提供定制服务 通过利用现有资源和实施 有效的运营计划,招募适当的人员,公布资源,并协助用户; 协助研究者获取适当的有效数据;通过支持研究者开发 全面、高质量、无偏见、高效、可靠和文化响应的研究设计,包括 那些解决方法上的偏见的方法;以及通过优先支持土著人民的健康差异CTR,特别是 功效试验(T3)和有效性试验(T4)以及采用和制度化试验(T5)。 具体目标2:通过以下方式提供关于健康差距减少技术转移方法的教育和培训: 指导联合执行/环境倡议使用适合合作减少风险的对外关系与发展工具和方法; 有利于职业发展的环境,强调准备和提交有价值的 联合执行/教育研究所的研究提案,特别是土著人民后裔的提案;设计和促进一个学术- 研究方法和过程的参与计划;并通过创建和促进一个新的外联 该计划旨在提供研究设计、数据分析和沟通方面的支持、指导和教育, 社区合作伙伴。 具体目标3:开发工具和方法,最大限度地提高健康差距的质量, 建立/整合CTR所必需的研究设计和生物统计学;通过创建设计和分析 对独特的、服务不足的或弱势群体的研究计划;通过推进设计和分析计划 为少数参与者开展研究;以及开发创新方法以提高统计能力。 到5年结束时,BERD核心将推进初级调查员和其他 过渡调查人员,特别是那些与IPP背景,支持他们的努力,以确保联邦 资助进行独立研究,旨在改善IPP和其他服务不足的人的健康, 夏威夷的弱势群体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EARL Shigemi HISHINUMA其他文献

EARL Shigemi HISHINUMA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EARL Shigemi HISHINUMA', 18)}}的其他基金

Biostatistics, Epidemiology, and Research Design Core
生物统计学、流行病学和研究设计核心
  • 批准号:
    10685391
  • 财政年份:
    2021
  • 资助金额:
    $ 54.31万
  • 项目类别:
Biostatistics, Epidemiology, and Research Design Core
生物统计学、流行病学和研究设计核心
  • 批准号:
    10474436
  • 财政年份:
    2021
  • 资助金额:
    $ 54.31万
  • 项目类别:
Asian/Pacific Islander Youth Violence Prevention Center
亚洲/太平洋岛民青少年暴力预防中心
  • 批准号:
    7496585
  • 财政年份:
    2005
  • 资助金额:
    $ 54.31万
  • 项目类别:
Asian/Pacific Islander Youth Violence Prevention Center
亚洲/太平洋岛民青少年暴力预防中心
  • 批准号:
    7272022
  • 财政年份:
    2005
  • 资助金额:
    $ 54.31万
  • 项目类别:
Asian/Pacific Islander Youth Violence Prevention Center
亚洲/太平洋岛民青少年暴力预防中心
  • 批准号:
    7279231
  • 财政年份:
    2005
  • 资助金额:
    $ 54.31万
  • 项目类别:
Asian/Pacific Islander Youth Violence Prevention Center
亚洲/太平洋岛民青少年暴力预防中心
  • 批准号:
    7021154
  • 财政年份:
    2005
  • 资助金额:
    $ 54.31万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 54.31万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 54.31万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 54.31万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 54.31万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了